Orgonex – RegMedXB Valorization Voucher Awarded

In 2022, Dr. Bart Spee and Dr. Kerstin Schneeberger were awarded a RegMed XB Thematic Transfer Voucher, facilitating market analysis for their innovative bioreactor technology, the RPMotion. Orgonex B.V., a new biotechnology firm based in Utrecht launched in 2023 by the duo, who are also affiliated to Utrecht University. The goal of Orgonex BV is to create groundbreaking hardware solutions in the field of organoid technology by reducing the effort of the current culturing methods in a sustainable way. This endeavor aims to accelerate organoid research and make it more cost-effective for scientists and companies in the field.